The latest PR news from the Holmes Report.
Opinion and commentary from the Holmes Report.
The Holmes Report's Echo Chamber PR show lifts the lid on key stories and trends.
Latest video interviews and campaigns from the Holmes Report.
Long-form journalism that analyzes the issues, challenges and opportunities facing the business and practice of PR.
Industry-leading analysis of the PR stories that matter.
Up close and personal with leaders from the marketing and PR worlds.
Keeping up with the latest thinking on PR industry expansion.
Coverage of the Cannes Lions from the Holmes Report in association with ICCO.
Coverage of the World Economic Forum in Davos.
The Holmes Report's annual analysis of the top reputation crises to rock the corporate sector.
The Holmes Report's annual forecast of trends that will impact the PR world in the year ahead.
Diversity & inclusion trends, views and analysis from the Holmes Report.
Creative work, trends and views from the global public relations industry.
Dedicated to exploring the new frontiers of PR as it dives deeper into social media, content and analytics.
Our coverage of key technology PR trends and challenges from around the world of digital communications.
From brand marketing to conscious consumerism, coverage of key marketing and PR trends worldwide.
Coverage of global corporate reputation and communications news and trends, from the leading online corporate PR news website The Holmes Report. Subscribe today!
The Holmes Report's coverage, analysis and news around the rapidly-shifting area of employee engagement and internal communications.
Sports PR news, diversity & inclusion trends, views and analysis from the Holmes Report. Subscribe today for the very latest in the world of sports communications.
The Holmes Report's definitive global benchmark of global PR agency size and growth, new for 2018.
The Holmes Report's annual selections for PR Agencies of the Year, across all of the world's major markets.
The world's 100 most powerful corporate communicators.
The Holmes Report profiles marketing and communications innovators from across North America, EMEA and Asia-Pac.
The most creatively awarded PR campaigns and agencies in the world.
In-depth annual research into the PR industry's efforts to raise creative standards.
The key global benchmark of PR agency rankings, industry size and global trends.
The world's biggest PR awards programme, dedicated to benchmarking the best PR work from across the globe.
The biggest PR conference of the year, a high-level forum designed for senior practitioners to address the critical issues that matter most.
Exploring the innovation and disruption that is redefining influence and engagement.
Unrivalled insight into the world's best PR agencies, across specialist and geographic categories.
Bringing together in-house comms leaders with PR firms to discuss critical global issues.
The PR industry’s most comprehensive listing of firms from every region and specialty
Find the latest global PR and communications jobs from the Holmes Report. From internships to account executives or directors. See all our PR jobs here.
Content from the Holmes Report's premium partners.
The Holmes Report's editorial series published in collaboration with partners.
Our 2015 North America PR Agencies of the Year are the result of an exhaustive research process involving more than 150 submissions and 50 face-to-face meetings with the best PR firms across the US and Canada.
Analysis of each of the Agencies of the Year and Finalists for each category can be accessed via the navigation menu to the right or here.
Upheaval in the pharmaceutical sector led to a difficult few years for healthcare PR specialists, but there are indications that the sector is bouncing back, led by a handful of firms that have expanded their client rosters to include non-pharma business and extended their offer to pharma companies to include more corporate reputation work and a more adventurous approach to digital and social media, integrating everything from online community building to paid media into traditional PR efforts.
GCI Health is in the forefront of those developments, working with clients in biotech (Biogen Idec, Genentech); medical technology (Medtronic, Bosch); the payer/provider community (Lenox Hill Hospital, the Hospital for Special Surgery); and associations (the TB Alliance, the American Academy of Nurse Practitioners) joining big pharma names like Allergan, Bayer, Boehringer Ingelheim, Johnson & Johnson, Merck, Novartis, Pfizer and Sanofi. As a result, the firm has tripled in size over the past five years and after 35 percent growth in 2014 now has fees comfortably in excess of $25 million.
The more integrated approach, encouraging clients to make use of digital and social channels, has been put into play for consumer brands like GSK’s Theraflu, but also for Bayer’s women’s health portfolio and its new IUD Skyla and building a community of 160,000 patients for Pfizer’s fibromyalgia business. The firm is also providing internal and external corporate communications support to clients, helping them deal with the change that continues to roil the sector and transform to meet the challenges of the future.
Just as impressive is GCI’s own thought leadership initiative, putting “Patients at the Center” of all its efforts, launched in October with a survey highlighting the gap between pharmaceutical companies’ intentions and their actual performance in this area, and a roundtable of leading patient advocacy groups.—PH
Chamberlain Healthcare PR (inVentiv Health)
Chamberlain began 2014 in recovery mode, having lost the substantial Pfizer oncology business in a consolidation the previous year. But the inVentiv Health agency rose to the challenge with vigor, maintaining its ability to translate the most complex science into compelling stories while diversifying its portfolio considerably beyond the core pharma business into biotech and specialty pharma and even some more consumer-oriented business.
The firm added the Novartis oncology business, and serves as agency of record for Amgen’s cardiovascular portfolio, helping to introduce the first new heart failure drug in nearly a decade; but it has also helped Novartis introduce a new treatment for psoriasis, creating a film that documented the real-life problems the condition creates for its sufferers. The firm has also worked with other inVentiv Health businesses on contract commercialization issues, helping specialty pharma company Emisphere bring to market Eligen B12, the first prescription tablet proven to normalize B12 levels without the need for an injection and working Aprecia on its ZipDose technology, a drug delivery platform that utilizes 3D printing.
There was considerable growth in the digital arena too, working with Novartis on some industry-first tweet chats and handling social media at industry events. While growth was modest in 2014, the firm ended the year with 50 people across its New York and London offices, and is on track for 25 percent growth in 2015.—PH
Cooney/Waters Group (Creston Unlimited)
As a network of agencies focused on healthcare, the Cooney/Waters Group (CWG) is known for translating complex science into bold, attention-grabbing campaigns. The group’s three brands all have a different area of the healthcare sector covered: Cooney/Waters known for pushing creative boundaries in its marketing comms work; public and private advocacy shop Alembic Health; and the issues-oriented Corkery Group.
Business rebounded last year after a challenging 2013 when CWG lost longtime client Sanofi-Pasteur.
In 2014, revenues grew 10% to $15.4m. The executive team led by president CEO Timothy Bird oversees a client list that includes the Abbott Fund, AbbVie, Novartis, the Coca-Cola Company, Purdue Pharma and the American Lung Association, among others.
Founded in 1992, the firm has evolved its offering as patients have increasingly turned to the Internet as their primary source of health information and engagement. CWG’s audience-centric approach is built on fostering dialogue, stimulating information sharing and content creation, and driving conversation across traditional and new channels. This is reflected in social network-based campaigns around Parkinson’s awareness; content development work for the Abbott Fund and experiential marketing for DJM Digital Solutions, among others. — AaS
JPA Health Communications (Independent)
Established in 2007, JPA has grown from a one-person band (founded by Carrie Jones) into a healthcare PR success story that now employs 20 staffers across offices in Washington DC, Boston and London. The firm’s focus on influencer relations, in particular, appears to have paid off, coupled with deep healthcare sector knowledge for nonprofit, pharmaceutical and government clients.
In 2014, JPA grew its fee income by more than 27% to $4.6m, driven in part by new business from Takeda, Together for Safer Roads, Global Bridges and Intuitive Surgical. They join a client roster that already features GenSpera, Intercept Pharmaceuticals, Chiasma, Lamaze International, Melanoma Research Foundation, Merck & Co., National Pharmaceutical Council, NIH’s National Center for Complementary and Integrative Health, Reagan-Udall Foundation for the FDA, BMS, Children's Hospital Association and ViiV Healthcare.
Jones remains the key leadership figure at JPA, supported by digital specialist Ken Deutsch in Boston and pharma veteran Valerie Carter in London. The team’s development of proprietary tools reflects its deep healthcare industry experience, helping to provide genuine insight into influencers, audiences and media.— AS
TogoRun—a specialist healthcare consultancy that operates as part of Omnicom’s FleishmanHillard—takes its name from Togo, a husky known for his role in the 1925 “Great Race of Mercy” to save a village in Alaska from an outbreak of diphtheria. It mission, fittingly, discusses “fearlessly navigating uncharted territory,” and its values including commitment, courage, creativity and craftsmanship. Those things are all easy to talk about, but TogoRun has been delivering on them since its foundation in 2009 (evolving from predecessor firm CPR Worldwide) and has been rewarded with impressive growth, with fees up by 32% in 2014 as the firm ended the year with 60 people in New York, Washington, Los Angeles and London, led by former Cohn & Wolfe executive Gloria Janata.
Longtime clients include Eli Lilly oncology; Bristol-Myers Squibb virology; Philips; and Novo Nordisk. Its work spans pharmaceutical and biotech, health information, technology and medical devices, medical aesthetics and beauty, health provider, coalitions, professional groups and non-profits, and animal health, with a formalized digital practice added in 2014. Interesting work included the award-winning Lilly Oncology On Canvas: Expressions of a Cancer Journey, a competition and touring exhibit, and for BMS the SHE (Strong HIV positive Empowered Women) global program, as well as work supporting Novo Nordisk’s new obesity franchise.—PH
We feel that the views of the reader are as important as the views of the writer. Please contact us at [email protected]Signup For Our Newsletter Media Kits/Editorial Calendar Jobs Postings Sitemap
© The Holmes Report 2020